ArticleJournal of breast cancer2020

Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status.

Jihye Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.